Folsan

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	35.4%
Systemic Lupus Erythematosus	8.8%
Drug Exposure During Pregnancy	8.0%
Rheumatoid Arthritis	6.2%
Depression	5.3%
Maternal Exposure During Pregnancy	4.4%
Thrombosis Prophylaxis	3.5%
Agitation	2.7%
Atrial Fibrillation	2.7%
Drug Use For Unknown Indication	2.7%
Osteopenia	2.7%
Pain	2.7%
Prophylaxis	2.7%
Pruritus	2.7%
Enteral Nutrition	1.8%
Epilepsy	1.8%
Hypertension	1.8%
Mineral Supplementation	1.8%
Tachycardia	1.8%
Constipation	0.9%

Drug Exposure During Pregnancy	17.6%
Haematoma	17.6%
Toxic Epidermal Necrolysis	17.6%
Vaginal Discharge	11.8%
Convulsion Neonatal	5.9%
Cyanosis	5.9%
Dysgeusia	5.9%
Foetal Exposure During Pregnancy	5.9%
Pre-eclampsia	5.9%
Stevens-johnson Syndrome	5.9%

Concomitant

Product Used For Unknown Indication	28.1%
Rheumatoid Arthritis	18.6%
Non-small Cell Lung Cancer	7.6%
Prophylaxis	7.5%
Drug Use For Unknown Indication	7.4%
Hypertension	5.4%
Pain	5.3%
Crohn's Disease	3.9%
Nausea	1.8%
Infection	1.8%
Psoriatic Arthropathy	1.6%
Depression	1.6%
Prophylaxis Against Gastrointestinal Ulcer	1.5%
Acute Myeloid Leukaemia	1.4%
Thrombosis Prophylaxis	1.3%
Epilepsy	1.1%
Anaemia	1.1%
Vitamin Supplementation	1.1%
Multiple Myeloma	1.0%
Osteoporosis Prophylaxis	1.0%

Pulmonary Embolism	8.5%
Thrombocytopenia	8.5%
Pneumonia	7.3%
Toxic Epidermal Necrolysis	6.2%
General Physical Health Deterioration	5.6%
Hypokalaemia	5.6%
Vomiting	5.6%
Weight Decreased	5.6%
Crohn's Disease	5.1%
Sepsis	5.1%
Splenic Infarction	4.5%
Neutropenia	4.0%
Pulmonary Tuberculosis	4.0%
Transplant Failure	4.0%
Diabetes Mellitus	3.4%
Electrocardiogram Qt Prolonged	3.4%
Premature Baby	3.4%
Retrognathia	3.4%
Rheumatoid Arthritis	3.4%
Tenosynovitis	3.4%